1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hyperoxia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abran, D; Almazan, G; Beauchamp, MH; Bernier, SG; Brault, S; Chemtob, S; Gobeil, F; Hou, X; Lachapelle, P; Marrache, AM; Peri, KG; Quiniou, C; Roberts, J; Varma, DR | 1 |
| Büttner, C; Frey, B; Jehle, R; Rüstow, B; Schlame, M; Sinha, P | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hyperoxia
| Article | Year |
|---|---|
Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy.
Topics: Animals; Cell Survival; Endothelium, Vascular; Humans; Hyperoxia; In Vitro Techniques; Injections; Microcirculation; Oxidative Stress; Oxygen; Pericytes; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Retinal Diseases; Retinal Vessels; Swine; Thromboxane A2; Vitreous Body | 2002 |
Platelet-activating factor (PAF)-acetylhydrolase and PAF-like compounds in the lung: effects of hyperoxia.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Bronchoalveolar Lavage Fluid; Hyperoxia; Lipid Peroxidation; Lung; Male; Phospholipases A; Platelet Activating Factor; Rats; Rats, Wistar | 2001 |